Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 482281 - 482300 out of 483377 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01ED05) lorlatinib (adm: O) | LORBRENA 25MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Pfizer,Inc. |
| USA | (L01ED05) lorlatinib (adm: O) | LORBRENA 25MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Pfizer,Inc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 50MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 50MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG ORAL GRANULES | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 125MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG + 200MG TAB | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EX02) sorafenib (adm: O) | SORAFENIB 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvKare,LLC |
| USA | (L01EX03) pazopanib (adm: O) | PAZOPANIB 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 120MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 120MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 160MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
Pages
